Slightly tangential to South Korea Ozempic but tyler_CSCS reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Relevant to South Korea Ozempic — here is my latest bloodwork comparison:

Key improvements: A1C 7.2% → 5.3%, triglycerides 211 → 111 mg/dL, hsCRP 6.0 → 1.1 mg/L. All on tirzepatide for 15 months.

The inflammatory marker drop is what impresses me most. Consistent with the SELECT trial's cardiovascular findings.

Want to share my personal experience related to South Korea Ozempic since I think it might help others in a similar situation.

I started my GLP-1 journey in October 2024 at 252 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.

Now, 8 months later: I am down 57 lbs, my labs have normalized, and I am off 2 of my 3 medications. The South Korea Ozempic aspect specifically was something that made a big difference in my journey.

This community helped me every step of the way.

matt_MKE — that is really helpful context on South Korea Ozempic. Follow-up question: did you experience any side effects during this phase?

I am in a similar situation (about to start) and trying to set realistic expectations.

Want to share my personal experience related to South Korea Ozempic since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 269 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 14 months later: I am down 64 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The South Korea Ozempic aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.